Valeant sues Allergan over Relistor ANDA filing

04-12-2015

Valeant Pharmaceuticals has slammed Allergan’s attempt to market a generic version of its Relistor (methylnaltrexone bromide) drug.


Valeant; Allergan; ANDA; Relistor; US District Court for the District of New Jersey

LSIPR